TABLE 4 .
Summary of POWV serologic data for TBD sample set
| Sample no. |
TBE-C EIA IgM |
POWV IFA IgM |
TBE-C EIA IgG |
POWV IFA IgG |
POWV PRNT90 titer |
|---|---|---|---|---|---|
| 10 | + | ≥1:20 | NDa | ND | ND |
| 11 | + | ≥1:20 | ND | ND | ND |
| 12b | ND | ND | + | ≥1:40 | ND |
| 13 | ND | ND | + | ≥1:40 | 1:160 |
| 14 | + | ≥1:20 | ND | ND | ND |
| 15 | + | ≥1:20 | ND | ND | ND |
| 16c | + | ≥1:20 | ND | ND | ND |
| 17 | + | ≥1:20 | ND | ND | ND |
| 18 | + | ≥1:20 | ND | ND | ND |
| 19 | + | ≥1:20 | + | ≥1:40 | 1:320 |
| 20 | + | ≥1:20 | ND | ND | ND |
a
ND, not detected at screening dilutions of 1:101 for TBE-C EIA, 1:20 for POWV IgM IFA, and 1:40 for POWV IgG IFA and 1:10 for POWV PRNT.
b
Sample tested positive for IgG antibodies to WNV.
c
POWV RNA detected in RT-PCR test.